Megan Elizabeth Bowles Clowse, MD

Associate Professor of Medicine
Campus mail Baker House 07, Duke South, Trent Drive, Durham, NC 27710
Phone (919) 681-2045
Email address megan.clowse@duke.edu

I am a clinical researcher with a focus on the management of rheumatologic diseases in pregnancy.  Since 2007, I have collected prospective pregnancies in women with rheumatic disease in the Duke Autoimmunity in Pregnancy Registry, which currently includes over 300 pregnancies.  This registry includes clinical data, pregnancy outcomes, and a large sample repository.  In collaboration with Duke Pediatric Cardiology, we found that maternal use of hydroxychloroquine may be protective against congenital heart block from neonatal lupus.  I have also conducted studies on vasculitis and ovarian function and pregnancy and I am the director of the Vasculitis-Pregnancy Registry, through the Vasculitis Clinical Research Consortium, is an online pregnancy registry for women with these rare conditions.  I am starting a study to identify causes for the high rate of infertility among women with rheumatoid arthrits.  I am also working on several projects to better understand how psoriatic arthritis impacts pregnancy.  

In Their Words

Education and Training

  • Fellow in Rheumatology, Medicine, Johns Hopkins University, 2002 - 2005
  • Medical Residetn, Medicine, Johns Hopkins University, 1999 - 2002
  • M.D., Vanderbilt University, 1999
  • M.P.H., University of California at Los Angeles, 1994

Publications

Clowse, MEB, and Petri, M. "Pregnancy and Systemic Lupus Erythematosus." Handbook of Systemic Autoimmune Diseases 4 (2005): 43-57.

Full Text

Clowse, MEB, Magder, LS, and Petri, M. "Complement and anti-double stranded DNA antibodies predict pregnancy outcomes in lupus patients." September 2004.

Scholars@Duke

Clowse, MEB, Magder, LS, and Petri, M. "Impact of the intensity and timing of lupus activity on pregnancy outcomes." September 2003.

Scholars@Duke

Clowse, MEB, and Wigley, FM. "Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis." J Rheumatol 30, no. 6 (June 2003): 1341-1343.

PMID
12784412
Scholars@Duke

Pages